EUVIMEDDescoperă EUVIMED
Open access · CC BY 4.0

O efeito no cérebro em desenvolvimento: a neurotoxicidade dos medicamentos psiquiátricos.

Mariana Silva de Melo, Adrielly Lorrane Azevedo Melo

Revista ft · 2026-11-18 · 30 (164) · 01-13

DOI: 10.69849/sbb54c93 ↗

At a glance

Journal article in Revista ft, published online on 2026-11-18. Written by Mariana Silva de Melo and 1 co-authors. The full text is freely available (open access, CC BY 4.0).

RezumatDate bibliograficeCiteRelated studies

Abstract (original language)

The final course project titled “The Effect on the Developing Brain: The Neurotoxicity of Psychiatric Medications,” authored by Mariana Silva de Melo, presents a narrative literature review aimed at critically analyzing available scientific evidence regarding the negative impacts of psychiatric medications on children and adolescents. The scientific rationale for the study stems from the significant increase in the use of psychotropic drugs within this age group over the last few decades, coupled with a growing body of evidence concerning potentially serious adverse effects in a particularly vulnerable population. The work highlights that safety data are available for only a small fraction of the adverse events assessed, revealing significant gaps in knowledge regarding the safety of most psychotropic drugs used by young people. Furthermore, the literature focuses primarily on short-term studies, which are insufficient for capturing rare but serious adverse events or long-term effects on neurological, cognitive, and metabolic development. Regarding its social impact, the study suggests that the systematized evidence could inform the formulation of public policies for child and adolescent mental health and the organization of psychosocial care services, while underscoring the need to strengthen evidence-based non-pharmacological approaches—such as psychotherapy and psychosocial interventions—which are frequently underutilized. Identifying particularly vulnerable groups, such as pre-pubertal children and those exposed to prolonged polypharmacy, could guide the development of more rigorous monitoring protocols and preventive strategies, thereby contributing to the reduction of iatrogenic harm and the promotion of a culture of rational medication use. The research question guiding this study is: what are the primary adverse effects associated with the use of psychiatric medications in children and adolescents, and how do these negative impacts manifest in metabolic, endocrine, neurological, and behavioral terms within this developing population? Based on the literature reviewed, these adverse effects manifest differently depending on the class of medication, with significant impacts on physical, metabolic, endocrine, neurological, and behavioral development. The general objective of this work is to critically analyze the available scientific evidence regarding the negative impacts of psychiatric medications on children and adolescents. Specific objectives include: describing the main adverse effects associated with the various classes of psychotropic drugs used in the pediatric and adolescent population—such as antidepressants, antipsychotics, medications for ADHD, and mood stabilizers; evaluating the magnitude and severity of metabolic, endocrine, cardiovascular, neurological, and psychiatric risks documented in the literature, with an emphasis on how these differ from those observed in the adult population; discussing the clinical implications of long-term adverse effects and withdrawal syndromes resulting from the discontinuation of psychotropic drugs; identifying knowledge gaps and priority areas for future research in pediatric and adolescent psychopharmacology; and analyzing the impact of polypharmacy and off-label prescribing on the safety profile of psychiatric medications in children and adolescents. The methodology adopted consists of a narrative literature review with a descriptive nature and a qualitative approach. The search for scientific articles was conducted in August 2026, using the electronic databases PubMed, Scopus, and Web of Science, in addition to consulting key specialized journals in the fields of child psychiatry and pharmacology, such as *World Psychiatry*, *Journal of the American Academy of Child & Adolescent Psychiatry*, and *Journal of Child and Adolescent Psychopharmacology*.

Cite

APA

Melo, M. S. D., & Melo, A. L. A. (2026). O efeito no cérebro em desenvolvimento: a neurotoxicidade dos medicamentos psiquiátricos. Revista ft, 30(164), 01-13. https://doi.org/10.69849/sbb54c93

Vancouver

Melo MSD, Melo ALA. O efeito no cérebro em desenvolvimento: a neurotoxicidade dos medicamentos psiquiátricos. Revista ft. 2026;30(164):01-13. doi:10.69849/sbb54c93

BibTeX
@article{Melo2026,
  author = {Melo, Mariana Silva de and Melo, Adrielly Lorrane Azevedo},
  title = {O efeito no cérebro em desenvolvimento: a neurotoxicidade dos medicamentos psiquiátricos},
  journal = {Revista ft},
  year = {2026},
  volume = {30},
  number = {164},
  pages = {01--13},
  doi = {10.69849/sbb54c93}
}
Start for free →